Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haemostasis Changes After Plasmapheresis With Fibrinogen Replacement
NCT03801135Unknown
- Sponsor
- University Medical Centre Ljubljana
- Start
- Oct 2018
- Primary completion
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of Fibrinogen human in hypofibrinogenemia and coagulation disorder (3 arms), sponsored by University Medical Centre Ljubljana. Primary endpoint: Effect of plasmapheresis replacement fluid type on fibrinogen level at 2 weeks. Status: unknown.
02
Drugs
Fibrinogen human
03
Conditions
hypofibrinogenemiacoagulation disorder
Beyond the preview
Go deeper on NCT03801135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03801135.